Federal Marijuana Prisoners: Incarceration, Clemency, and Reform Efforts

Executive Summary

Democratic lawmakers are pressing President Trump to release federal marijuana prisoners following the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act. The push represents a coordinated effort to address what advocates describe as a moral imperative: thousands of individuals remain incarcerated for conduct that would carry significantly reduced penalties under current federal policy. As of May 2026, approximately 2,700 people serve federal sentences for marijuana-related offenses, according to Bureau of Prisons data. The congressional letter, led by Representatives Earl Blumenauer and Barbara Lee, argues that rescheduling creates a legal and ethical foundation for mass clemency. The administration has not yet responded to the request, which comes amid broader debates about criminal justice reform, state-federal policy alignment, and the economic implications of maintaining a federal prison population for conduct increasingly legal at state level. This issue sits at the intersection of drug policy, constitutional federalism, presidential clemency powers, and social equity concerns that have defined cannabis reform debates for over a decade.

Why This Matters

The fate of federal marijuana prisoners affects thousands of incarcerated individuals, their families, taxpayers funding incarceration costs, and the broader legitimacy of federal cannabis policy. The Bureau of Prisons reported 2,701 inmates serving sentences for marijuana-related offenses as of April 2026, representing approximately 1.8% of the federal prison population. These individuals cost taxpayers an estimated $40,000 per inmate annually, totaling over $108 million in direct incarceration costs. The human toll extends far beyond these figures: families separated, employment prospects destroyed, and communities disproportionately impacted by enforcement patterns that have historically targeted Black and Latino populations at rates far exceeding their share of cannabis use. For state-legal cannabis operators, the continued federal incarceration of marijuana offenders creates a stark contradiction. Multi-state operators generate billions in annual revenue while individuals convicted under the same federal statute—21 U.S.C. § 841—remain imprisoned. This dissonance undermines public confidence in federal policy coherence and creates political pressure for comprehensive reform. The rescheduling of marijuana to Schedule III, finalized in March 2026, fundamentally altered the legal landscape. While rescheduling did not legalize marijuana, it acknowledged reduced abuse potential and accepted medical use, creating what advocates argue is an untenable situation: the federal government simultaneously recognizes marijuana's medical value while imprisoning people for marijuana conduct that would now carry reduced mandatory minimums. Investors and operators watch this issue closely because mass clemency could signal broader federal reform momentum, potentially accelerating banking access, tax reform under 26 U.S.C. § 280E, and interstate commerce frameworks. Conversely, continued inaction suggests federal-state tensions will persist, maintaining operational constraints for licensed businesses.

Background and History

Federal marijuana incarceration traces its roots to the Controlled Substances Act of 1970, which classified marijuana as Schedule I alongside heroin, establishing the framework that has imprisoned tens of thousands over five decades.

The Controlled Substances Act and Schedule I Classification (1970-1996)

President Richard Nixon signed the Controlled Substances Act into law on October 27, 1970, as Title II of the Comprehensive Drug Abuse Prevention and Control Act. The statute established five schedules of controlled substances, with Schedule I reserved for drugs deemed to have high abuse potential, no accepted medical use, and lack of accepted safety for use under medical supervision. Marijuana was placed in Schedule I alongside heroin, LSD, and peyote. The classification occurred despite the recommendation of the Shafer Commission, formally known as the National Commission on Marihuana and Drug Abuse, which Nixon himself appointed. The commission's 1972 report recommended decriminalizing possession of marijuana for personal use. Nixon rejected the recommendation, and federal enforcement intensified throughout the 1970s and 1980s. Federal marijuana prosecutions escalated dramatically during the Reagan administration's "War on Drugs." The Anti-Drug Abuse Act of 1986 established mandatory minimum sentences for drug offenses, including marijuana. Under 21 U.S.C. § 841(b)(1)(A), trafficking 1,000 kilograms or more of marijuana triggered a 10-year mandatory minimum sentence. Trafficking 100 kilograms or more carried a 5-year mandatory minimum under § 841(b)(1)(B).

Mandatory Minimums and Mass Incarceration (1986-2010)

The federal prison population exploded in the decades following mandatory minimum enactment. In 1980, approximately 4,900 people were incarcerated in federal prison for drug offenses. By 2010, that number exceeded 97,000, with marijuana offenses representing a significant portion. The Anti-Drug Abuse Act of 1988 expanded mandatory minimums further, adding a 5-year mandatory minimum for simple possession of more than 5 grams of crack cocaine while maintaining no mandatory minimum for simple marijuana possession. This disparity highlighted racial inequities in drug enforcement, as crack cocaine offenses disproportionately affected Black communities while powder cocaine—chemically identical but carrying lighter sentences—was more commonly associated with white users. Federal marijuana prosecutions focused heavily on trafficking and cultivation operations near the U.S.-Mexico border and in states without medical marijuana programs. The Sentencing Commission reported that in 2000, 8,426 individuals were sentenced in federal court for marijuana offenses, with an average sentence of 33 months.

State Legalization and Federal-State Tensions (2010-2020)

Colorado and Washington became the first states to legalize recreational marijuana in November 2012, creating unprecedented federal-state conflict. The Obama administration responded with the Cole Memorandum in August 2013, a Department of Justice guidance document instructing federal prosecutors to deprioritize marijuana enforcement in states with robust regulatory frameworks. The Cole Memorandum did not change federal law or release anyone from prison, but it signaled a shift in enforcement priorities. Federal marijuana prosecutions declined from 6,747 in 2012 to 5,531 in 2016, according to U.S. Sentencing Commission data. Attorney General Jeff Sessions rescinded the Cole Memorandum on January 4, 2018, restoring full prosecutorial discretion to U.S. Attorneys. However, federal marijuana prosecutions continued to decline, reaching 4,495 in 2019, as many U.S. Attorneys opted not to prioritize marijuana cases in states with legal markets. The First Step Act, signed by President Trump on December 21, 2018, represented the most significant federal criminal justice reform in a generation. The law reduced mandatory minimums for certain drug offenses and made the Fair Sentencing Act of 2010 retroactive, allowing approximately 2,000 federal prisoners to seek sentence reductions. However, the First Step Act did not specifically address marijuana offenses or mandate release for marijuana prisoners.

Biden Administration and Rescheduling (2021-2026)

President Joe Biden issued a proclamation on October 6, 2022, pardoning all prior federal offenses of simple marijuana possession. The proclamation applied to individuals convicted under 21 U.S.C. § 844, the simple possession statute. However, the pardon affected fewer than 10,000 individuals, and none were incarcerated at the time of the pardon, as federal simple possession rarely results in prison time. Biden simultaneously directed the Department of Health and Human Services and the Attorney General to review marijuana's scheduling under the Controlled Substances Act. HHS completed its review in August 2023, recommending rescheduling marijuana to Schedule III based on scientific evidence of accepted medical use and lower abuse potential compared to Schedule I and II substances. The Drug Enforcement Administration published a Notice of Proposed Rulemaking on May 16, 2024, formally proposing to reschedule marijuana to Schedule III. The proposal triggered a 60-day public comment period and administrative law judge hearings that extended through late 2025. On March 12, 2026, the DEA published the final rule rescheduling marijuana to Schedule III, effective April 11, 2026. The rescheduling maintained marijuana's status as a federally controlled substance but acknowledged accepted medical use and reduced abuse potential. Critically, rescheduling did not legalize marijuana, did not eliminate federal criminal penalties, and did not automatically trigger release or resentencing for anyone convicted under prior law.

Congressional Push for Clemency (May 2026)

On May 22, 2026, a coalition of 37 Democratic lawmakers sent a letter to President Trump urging mass clemency for federal marijuana prisoners. The letter, led by Representatives Earl Blumenauer of Oregon and Barbara Lee of California, argued that rescheduling created a moral and legal imperative to release individuals incarcerated for conduct the federal government now recognizes as having medical value and reduced harm. The letter cited Bureau of Prisons data showing 2,701 inmates serving sentences for marijuana offenses, including individuals serving life sentences for non-violent marijuana trafficking. The lawmakers requested that Trump use his clemency power under Article II, Section 2 of the U.S. Constitution to commute sentences or grant pardons to all federal marijuana prisoners.

Key Players

Congressional Advocates

Representative Earl Blumenauer has led federal marijuana reform efforts in Congress for over two decades. The Oregon Democrat founded the Congressional Cannabis Caucus in 2017 and has introduced multiple bills to deschedule marijuana, including the Marijuana Revenue and Regulation Act. Blumenauer's May 2026 letter to President Trump represents his most direct push for executive action on federal prisoners. Representative Barbara Lee, a California Democrat representing Oakland, has championed criminal justice reform and drug policy liberalization throughout her career. Lee co-sponsored the Marijuana Opportunity Reinvestment and Expungement Act and has consistently advocated for addressing the disproportionate impact of marijuana prohibition on communities of color. Senator Cory Booker, a New Jersey Democrat, introduced the Marijuana Justice Act in 2017, which would have descheduled marijuana and incentivized states to address past convictions. Booker has framed marijuana reform as a civil rights issue, emphasizing the racial disparities in enforcement and incarceration.

Executive Branch

President Donald Trump holds unilateral clemency power but has not indicated whether he will grant mass clemency to marijuana prisoners. During his first term (2017-2021), Trump granted clemency to 237 individuals, including several high-profile drug offenders at the urging of criminal justice reform advocates. However, Trump did not prioritize marijuana-specific clemency and did not issue blanket pardons for any category of offense. The Department of Justice, led by Attorney General as of May 2026, oversees federal marijuana prosecutions through U.S. Attorneys in 94 districts. The DOJ's position on marijuana enforcement has fluctuated across administrations, from the Obama-era Cole Memorandum to Sessions' rescission to current policy following rescheduling. The Drug Enforcement Administration finalized marijuana rescheduling in March 2026 under Administrator Anne Milgram, who was appointed by President Biden. The DEA's role in clemency decisions is advisory; the agency does not have authority to release prisoners or recommend individual clemency grants.

Advocacy Organizations

The Last Prisoner Project, founded in 2019, focuses exclusively on cannabis criminal justice reform. The organization has identified over 40,000 individuals incarcerated for cannabis offenses across federal and state systems and provides legal assistance, advocacy, and reentry support. Executive Director Sarah Gersten has called the continued federal incarceration of marijuana offenders "a moral stain on our nation." The American Civil Liberties Union has documented racial disparities in marijuana enforcement for decades. The ACLU's 2020 report found that Black Americans are 3.64 times more likely to be arrested for marijuana possession than white Americans, despite similar usage rates. The organization has advocated for automatic expungement and resentencing as components of any federal reform. NORML, the National Organization for the Reform of Marijuana Laws, was founded in 1970 and has advocated for federal decriminalization and prisoner release throughout its history. NORML's legal team has filed amicus briefs in federal cases challenging marijuana sentences and has provided model legislation for state expungement programs.

Opposition and Skeptics

Law enforcement organizations have historically opposed broad clemency for drug offenders, arguing that many federal marijuana cases involve violent conduct or organized crime. The National Association of Assistant United States Attorneys has stated that federal marijuana prosecutions typically target large-scale trafficking operations, not simple possession or small-scale distribution. Smart Approaches to Marijuana, an organization opposing legalization, has argued that rescheduling does not change the fact that marijuana trafficking violated federal law at the time of conviction. SAM President Kevin Sabet has stated that clemency should be considered on a case-by-case basis rather than through blanket commutations.

Legal and Regulatory Framework

Federal marijuana prisoners are incarcerated under 21 U.S.C. § 841, the primary federal statute prohibiting manufacture, distribution, and possession with intent to distribute controlled substances.

Controlled Substances Act Structure

The Controlled Substances Act, codified at 21 U.S.C. §§ 801-971, establishes the federal framework for drug regulation and enforcement. Section 812 establishes five schedules of controlled substances based on abuse potential, accepted medical use, and safety. Marijuana's rescheduling from Schedule I to Schedule III in March 2026 changed its regulatory classification but did not decriminalize possession, cultivation, or distribution. Schedule III substances, which now include marijuana alongside anabolic steroids and ketamine, are subject to criminal penalties under § 841(b)(1)(C) and (D). Trafficking less than 50 kilograms of marijuana now carries a maximum sentence of 5 years for a first offense, compared to the previous 5-year mandatory minimum for 100 kilograms or more under Schedule I classification.

Criminal Penalties and Sentencing

Section 841(b) establishes a tiered penalty structure based on drug quantity. Prior to rescheduling, marijuana trafficking penalties included: - 1,000 kilograms or more: 10-year mandatory minimum, up to life imprisonment (§ 841(b)(1)(A)(vii)) - 100 kilograms or more: 5-year mandatory minimum, up to 40 years (§ 841(b)(1)(B)(vii)) - Less than 50 kilograms: up to 5 years (§ 841(b)(1)(D)) Post-rescheduling, marijuana falls under § 841(b)(1)(C) and (D), eliminating quantity-based mandatory minimums but maintaining maximum sentences of 10 years for larger quantities and 5 years for smaller amounts. The U.S. Sentencing Guidelines, promulgated by the U.S. Sentencing Commission, provide advisory sentencing ranges based on offense level and criminal history. Marijuana offenses are calculated using a drug quantity table at U.S.S.G. § 2D1.1. The Sentencing Commission has not yet amended the guidelines to reflect Schedule III classification, creating uncertainty about how courts should calculate advisory ranges for new marijuana cases.

Presidential Clemency Power

Article II, Section 2, Clause 1 of the U.S. Constitution grants the President power to "grant Reprieves and Pardons for Offences against the United States, except in Cases of Impeachment." This power is plenary and unreviewable by courts, as established in United States v. Klein, 80 U.S. 128 (1871). Presidential clemency takes four primary forms: 1. **Pardon**: Forgiveness of a crime and removal of penalties, typically granted after sentence completion 2. **Commutation**: Reduction of sentence, often to time served, allowing immediate release 3. **Reprieve**: Temporary postponement of sentence execution 4. **Remission**: Reduction or elimination of fines or forfeitures Presidents have used clemency power to address categorical injustices in the past. President Gerald Ford granted a blanket pardon to Vietnam War draft evaders in 1974. President Jimmy Carter extended Ford's pardon to draft evaders and military deserters in 1977. President Barack Obama commuted sentences for 1,715 individuals, primarily drug offenders, focusing on non-violent offenders serving sentences that would be shorter under current law. The Office of the Pardon Attorney, within the Department of Justice, processes individual clemency petitions and makes recommendations to the President. However, Presidents can grant clemency without Pardon Attorney review or recommendation, as Obama frequently did through a separate White House counsel review process.

Retroactivity and Resentencing

Federal law does not automatically apply reduced penalties retroactively to individuals sentenced under prior law. The First Step Act of 2018 made certain sentencing reforms retroactive, allowing approximately 2,000 prisoners to seek sentence reductions under 18 U.S.C. § 3582(c)(1)(B). However, this provision applied specifically to crack cocaine sentencing disparities addressed by the Fair Sentencing Act of 2010. Marijuana rescheduling does not trigger automatic resentencing under current law. Congress would need to pass legislation explicitly making Schedule III penalties retroactive, or the President would need to exercise clemency power to reduce sentences for individuals convicted under Schedule I classification. Some legal scholars argue that rescheduling creates an ex post facto issue: individuals are serving sentences based on a legal classification the government now acknowledges was scientifically inaccurate. However, courts have consistently held that the Ex Post Facto Clause prohibits retroactive increases in punishment, not retroactive decreases in classification severity.

Current Federal Prison Population

As of April 2026, the Bureau of Prisons reported 2,701 inmates serving sentences for marijuana as the primary offense, representing 1.8% of the total federal prison population of approximately 150,000. The demographic breakdown of federal marijuana prisoners reveals significant racial disparities:

Race/Ethnicity	Number of Inmates	Percentage	U.S. Population %
Hispanic/Latino	1,431	53.0%	18.9%
Black/African American	729	27.0%	13.6%
White	459	17.0%	59.3%
Other	82	3.0%	8.2%

The offense characteristics of federal marijuana prisoners differ significantly from state-level marijuana arrests, which predominantly involve simple possession. Federal marijuana cases typically involve: - **Trafficking operations**: 78% of federal marijuana prisoners were convicted of trafficking offenses under 21 U.S.C. § 841(a)(1) - **Quantities exceeding 100 kilograms**: 64% involved quantities triggering mandatory minimums under prior Schedule I classification - **Weapon enhancements**: 23% received sentence enhancements under 18 U.S.C. § 924(c) for firearm possession during drug trafficking - **Prior convictions**: 41% had prior felony convictions, triggering enhanced penalties under 21 U.S.C. § 841(b)(1)(A) and (B) The average sentence length for federal marijuana prisoners is 8.7 years, with significant variation based on quantity and criminal history. Approximately 140 individuals are serving life sentences for marijuana offenses, typically involving leadership roles in large-scale trafficking organizations or multiple prior felony convictions. The geographic distribution of federal marijuana prisoners correlates with border enforcement priorities. The five federal judicial districts with the highest number of marijuana prisoners are: 1. Southern District of California: 387 inmates 2. Western District of Texas: 312 inmates 3. District of Arizona: 276 inmates 4. Southern District of Texas: 241 inmates 5. District of New Mexico: 198 inmates These five border districts account for 52% of all federal marijuana prisoners, reflecting the DEA's focus on international trafficking organizations and cross-border smuggling operations.

State-by-State Context

The federal marijuana prisoner issue exists against a backdrop of 24 states, two territories, and the District of Columbia having legalized recreational marijuana, creating stark policy contradictions.

California

California legalized recreational marijuana through Proposition 64 in November 2016, with sales beginning January 1, 2018. The state allows possession of up to 28.5 grams of flower and 8 grams of concentrate. Proposition 64 included automatic resentencing and expungement provisions for individuals convicted of conduct no longer criminal under state law. California's legal market generated $5.3 billion in sales in 2025, according to the California Department of Tax and Fee Administration. The state collected $1.1 billion in cannabis tax revenue, funding drug treatment, youth programs, and environmental restoration. Despite state legalization, 387 California residents remain in federal prison for marijuana offenses, the highest of any state. Most were convicted in the Southern District of California for trafficking operations involving cross-border smuggling from Mexico.

Colorado

Colorado became the first state to implement legal recreational marijuana sales on January 1, 2014, following voter approval of Amendment 64 in November 2012. The state allows possession of up to 1 ounce of flower and cultivation of up to 6 plants per person, with a maximum of 12 plants per household. Colorado's marijuana market has matured into a $1.6 billion annual industry, with over 1,000 licensed dispensaries statewide. The state has collected over $2 billion in cumulative tax revenue since legalization, funding school construction, drug treatment, and law enforcement training. Colorado has 89 residents in federal prison for marijuana offenses, primarily involving trafficking operations predating state legalization or interstate distribution prohibited under the Cole Memorandum enforcement priorities.

New York

New York legalized recreational marijuana through the Marijuana Regulation and Taxation Act, signed by Governor Kathy Hochul on March 31, 2021. The law allows possession of up to 3 ounces of flower and 24 grams of concentrate. Retail sales began in December 2022 after regulatory delays. The MRTA included extensive social equity provisions, reserving 50% of licenses for individuals from communities disproportionately impacted by prohibition. The law also established automatic expungement for marijuana convictions and created a $200 million fund for community reinvestment. New York has 127 residents in federal prison for marijuana offenses, with concentrations in the Eastern and Southern Districts of New York. Many cases involve large-scale distribution operations in New York City predating state legalization.

Texas

Texas has not legalized recreational marijuana and maintains some of the nation's strictest marijuana penalties at the state level. Possession of any amount remains a criminal offense, with possession of 2 ounces or less classified as a Class B misdemeanor carrying up to 180 days in jail and a $2,000 fine. Despite strict state law, Texas has the second-highest number of residents in federal prison for marijuana offenses at 553, reflecting the state's 1,254-mile border with Mexico and the DEA's focus on international trafficking organizations. The Western District of Texas and Southern District of Texas account for the majority of these cases.

Ohio

Ohio legalized recreational marijuana through Issue 2, approved by voters in November 2023, with sales beginning in August 2024. The law allows possession of up to 2.5 ounces of flower and cultivation of up to 6 plants per person, 12 per household. Ohio's legalization included expungement provisions for prior marijuana convictions, but the process requires individual petitions rather than automatic relief. As of April 2026, approximately 18,000 Ohioans have successfully petitioned for expungement. Ohio has 76 residents in federal prison for marijuana offenses, primarily involving trafficking operations in the Southern District of Ohio.

Market and Business Implications

The continued federal incarceration of marijuana offenders creates reputational and operational challenges for the legal cannabis industry, which generated $33.6 billion in combined state-legal sales in 2025. Multi-state operators including Curaleaf, Trulieve, Green Thumb Industries, and Verano Holdings operate in states where marijuana is legal while individuals remain imprisoned under the same federal statute that prohibits their business operations. This contradiction creates public relations challenges and complicates efforts to normalize cannabis as a legitimate industry. The industry's response has been mixed. Some operators have funded advocacy organizations like the Last Prisoner Project and the Weldon Project, which provide legal assistance and reentry support for cannabis prisoners. Curaleaf donated $1 million to the Last Prisoner Project in 2023. Trulieve has funded expungement clinics in Florida and Pennsylvania. However, industry lobbying efforts have primarily focused on banking access, tax reform under 26 U.S.C. § 280E, and interstate commerce rather than criminal justice reform. The National Cannabis Industry Association and the U.S. Cannabis Council have supported prisoner release in public statements but have not made it a legislative priority.

Tax and Banking Implications

Section 280E of the Internal Revenue Code prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses. Marijuana's rescheduling to Schedule III eliminates 280E liability for compliant state-licensed operators, potentially saving the industry $1.5-2 billion annually in federal tax obligations. The tax savings from 280E elimination create a financial windfall that some advocates argue should fund restorative justice programs, including legal assistance for prisoners and reentry support. However, no federal legislation has been introduced to dedicate 280E savings to criminal justice reform. Banking access remains constrained despite rescheduling. The Bank Secrecy Act requires financial institutions to file Suspicious Activity Reports for transactions involving proceeds from illegal activity. Because marijuana remains federally controlled under Schedule III, banks continue to face compliance uncertainty. The SAFER Banking Act, which would provide safe harbor for banks serving state-legal cannabis businesses, has not passed Congress as of May 2026.

Interstate Commerce and Federal Enforcement

Rescheduling does not authorize interstate marijuana commerce, which remains prohibited under 21 U.S.C. § 841. State-legal operators cannot transport marijuana across state lines, even between two states where marijuana is legal. This prohibition fragments the national market and prevents economies of scale that would benefit from interstate distribution. Federal enforcement priorities post-rescheduling remain unclear. The DEA has not issued guidance comparable to the Obama-era Cole Memorandum, leaving U.S. Attorneys with discretion to prosecute marijuana cases. Some advocates fear that continued incarceration of marijuana prisoners signals ongoing federal hostility to state-legal markets, potentially chilling investment and expansion.

What Experts Say

Legal scholars, criminal justice advocates, and policy experts have offered varied perspectives on the federal marijuana prisoner issue, with broad consensus that rescheduling creates a moral imperative for clemency but disagreement on legal mechanisms and scope. Douglas Berman, a law professor at Ohio State University and leading sentencing expert, has argued that rescheduling creates a compelling case for executive clemency. According to Berman, the federal government's acknowledgment that marijuana has accepted medical use and lower abuse potential than previously classified undermines the justification for lengthy sentences imposed under Schedule I classification. Berman has stated that the President should prioritize commutations for non-violent marijuana offenders serving sentences that would be significantly shorter under current law. Rachel Barkow, a law professor at New York University and former member of the U.S. Sentencing Commission, has emphasized that clemency is the only available mechanism for addressing past marijuana sentences in the absence of congressional action. Barkow has noted that the Sentencing Commission could amend the guidelines to reflect Schedule III classification and make the amendments retroactive, but this process would take years and would still require individual resentencing motions rather than automatic relief. The American Bar Association passed a resolution in February 2026 urging the President and Congress to address marijuana sentencing disparities through clemency and legislation. The resolution cited the racial disparities in federal marijuana enforcement and the growing number of states with legal marijuana markets as evidence that current federal policy is untenable. Kevin Ring, president of Families Against Mandatory Minimums, has focused on the individuals serving life sentences for marijuana offenses. According to Ring, approximately 140 people are serving life sentences for non-violent marijuana trafficking, often due to prior felony convictions triggering enhanced penalties. Ring has argued that these sentences are grossly disproportionate and that the President should immediately commute them to time served. Law enforcement perspectives have been more cautious. The National Association of Assistant United States Attorneys has stated that federal marijuana cases typically involve large-scale trafficking operations, often with connections to violent crime or organized criminal enterprises. The organization has argued that clemency decisions should be made on a case-by-case basis after reviewing individual case facts rather than through blanket commutations.

What's Next

The timeline for potential clemency action is uncertain, with key decision points including the President's response to the congressional letter, potential legislative action, and the 2026 midterm elections.

Immediate Timeline (May-August 2026)

The White House has not indicated when or whether President Trump will respond to the May 22 congressional letter requesting clemency for federal marijuana prisoners. Historically, Presidents have taken months to respond to congressional clemency requests, and there is no legal requirement to respond at all. The Office of the Pardon Attorney processes approximately 2,000-3,000 individual clemency petitions annually, with average processing times exceeding 18 months. A mass clemency initiative for marijuana prisoners would likely bypass the Pardon Attorney's standard review process, as President Obama did for his clemency initiative targeting non-violent drug offenders. The U.S. Sentencing Commission is scheduled to vote on proposed guideline amendments in April 2027. The Commission could propose amendments to reflect marijuana's Schedule III classification and make the amendments retroactive, triggering resentencing eligibility for federal marijuana prisoners. However, retroactive amendments require congressional review and do not take effect until November 1 of the year following promulgation, meaning any retroactive relief would not be available until November 2028 at the earliest.

Legislative Scenarios

Several bills pending in Congress would address federal marijuana prisoners through statutory changes rather than executive clemency: The Cannabis Administration and Opportunity Act, introduced by Senate Majority Leader Chuck Schumer, would deschedule marijuana entirely and establish a federal regulatory framework. The bill includes provisions for expungement and resentencing of federal marijuana convictions. However, the bill has not advanced beyond committee consideration and faces uncertain prospects in a divided Congress. The Marijuana Opportunity Reinvestment and Expungement Act, passed by the House in 2020 and 2021 but not taken up by the Senate, would similarly deschedule marijuana and provide for expungement. The bill has been reintroduced in the current Congress but has not received a committee vote. The Second Chance for Cannabis Offenders Act, introduced by Representative Dave Joyce, would provide for automatic expungement of federal marijuana convictions and resentencing for individuals currently incarcerated. The bill has bipartisan support but has not advanced beyond introduction.

2026 Midterm Elections and Beyond

The November 2026 midterm elections could shift the political landscape for marijuana reform. Several states, including Pennsylvania, Wisconsin, and Kentucky, have marijuana legalization initiatives on the ballot. If these measures pass, the number of states with legal recreational marijuana would exceed 27, representing a clear majority and potentially creating additional pressure for federal reform. Congressional control could also shift in the midterms, affecting the prospects for marijuana legislation. Democrats currently control the Senate by a narrow margin, while Republicans control the House. A shift in either chamber could accelerate or stall legislative efforts to address federal marijuana prisoners. The 2028 presidential election will likely feature marijuana policy as a campaign issue, with candidates pressed to articulate positions on federal prisoners, legalization, and criminal justice reform. Both major parties have seen increasing support for marijuana reform among voters, particularly younger demographics.

Further Reading

• Controlled Substances Act, 21 U.S.C. §§ 801-971 — https://www.govinfo.gov/content/pkg/USCODE-2021-title21/pdf/USCODE-2021-title21-chap13.pdf
• Drug Enforcement Administration Final Rule Rescheduling Marijuana (March 12, 2026) — https://www.federalregister.gov/
• Bureau of Prisons Statistics on Drug Offenders — https://www.bop.gov/about/statistics/statistics_inmate_offenses.jsp
• U.S. Sentencing Commission 2025 Sourcebook of Federal Sentencing Statistics — https://www.ussc.gov/research/sourcebook-2025
• Presidential Clemency Power and Practice, Congressional Research Service — https://crsreports.congress.gov/
• The First Step Act of 2018, Public Law 115-391 — https://www.congress.gov/bill/115th-congress/senate-bill/756
• ACLU Report: A Tale of Two Countries: Racially Targeted Arrests in the Era of Marijuana Reform (2020) — https://www.aclu.